$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The cure rate of Pitobrutinib/Pitobrutinib is revealed, the data that patients care about is here!
2026-02-01 22:25:32
Check Details
How many tablets of talazoparib/talazopanib should be taken per day? Correct Medication Dosage and Taking Guidelines
2026-02-01 22:25:32
Check Details
How many years can you live taking Crizotinib/Xalkori? Comprehensive analysis of efficacy and survival
2026-02-01 22:25:32
Check Details
Whether serputinib/serpatinib has been included in the medical insurance system
2026-02-01 22:25:32
Check Details
FDA approves nivolumab plus ipilimumab for unresectable or metastatic hepatocellular carcinoma
2026-02-01 22:25:32
Check Details
How much do you know about Ensidipine in Laos? This article will take you into this overseas drug!
2026-02-01 22:25:32
Check Details
Possible adverse reactions of Avatrombopag/Sucoxin
2026-02-01 22:25:32
Check Details
Is giritinib a targeted drug? Analysis of pharmacological mechanisms and clinical applications
2026-02-01 22:25:32
Check Details
Is midostaurin, a specific leukemia drug, suitable for all AML patients? What tests should be done
2026-02-01 22:25:32
Check Details
How effective is molotinib/mometinib in the treatment of myelofibrosis? Clinical efficacy and usage experience
2026-02-01 22:25:32
Check Details
The relationship between the taking time and efficacy of deuterated colexitinib
2026-02-01 22:25:32
Check Details
How effective is the Lao version of Valganciclovir? Comparison with other versions
2026-02-01 22:25:32
Check Details
1
2
...
1484
1485
1486
1487
1488
1489
1490
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
2
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
3
Filgotinib: Mechanism of Action and Clinical Applications Explained
4
Lapatinib: Proper Administration Guide and Key Precautions
5
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
6
Cemiplimab Storage and Handling Guide
7
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
8
FDA Approves First mRNA Flu Vaccine mFLUSIVA
9
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
10
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
11
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
12
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring